Treatment With XPro1595 Promotes Remyelination in Mouse Model
The experimental therapy XPro1595 was found to promote remyelination — the repair of the myelin sheath — in a mouse…
Articles by Marisa Wexler, MS
Keto Diet Improved Life Quality of RRMS Patients in Trial
Eating a ketogenic diet — one low in carbohydrates and high in fats — led to markedly less fatigue and…
Study Finds New Molecules Targeted by the Immune System
Researchers have identified four new brain proteins that are targeted by inflammatory T-cells in multiple sclerosis (MS), which could…
Cannabis ‘Highly Effective’ Against MS Symptoms, Some Users Report
More than half of Canadians with multiple sclerosis (MS) report using cannabis to help manage their symptoms, according to…
Tysabri Every 6 Weeks Found as Effective as Standard 4-week Dosing
Tysabri (natalizumab) given every six weeks was found to be similarly effective as the standard four-week dosing schedule at…
NICE Briefing Covers Icobrain System for Automated MRI Scans
The National Institute for Health and Care Evidence (NICE) in England has issued a briefing on the use of Icometrix‘s…
#AAN2022 – Tolebrutinib Reduces Brain Damage Up to 1.5 Years in Trial
Long-term treatment with tolebrutinib significantly reduced signs of disease-related brain damage in people with relapsing multiple sclerosis (MS),…
#AAN2022 – For Children With MS, Symptoms May Predict Future Disability
Children with multiple sclerosis (MS) who in their first year after disease onset experience pyramidal symptoms, such as spasticity…
Trial of Metformin-Clemastine Combo Enrolls First Patient
The first participant has been enrolled in a new clinical trial that is testing whether an antihistamine in combination with…
#AAN2022 – More Patients Given Ublituximab Relapse-free in Trials
More relapsing multiple sclerosis (MS) patients given ublituximab remained relapse-free over the two-year long Phase 3 ULTIMATE clinical trials, compared to those…
Data Is Lacking on Safety of MS Treatments During Breastfeeding
There is minimal data available on the safety of most disease-modifying therapies for multiple sclerosis (MS) when used during…
Progressive MS Trial Finds Repeat Bone Marrow Infusion Safe, Feasible
Repeat harvesting of bone marrow cells and infusing them back into the bloodstream is safe and feasible in people with…
Equal DMT Use Found in Norway Despite Socioeconomic Status: Study
People newly diagnosed with multiple sclerosis (MS) in Norway have in recent years received disease-modifying therapies (DMTs) independent…
Vumerity Added to NHS of England for People With Active RRMS
The National Institute for Health and Care Excellence (NICE) has added oral Vumerity (diroximel fumarate), approved to treat relapsing-remitting multiple…
Behavioral Training May Help MS Patients Recognize Facial Expressions
An intervention that involves training to recognize facial expressions, and also mimicking these expressions, may help people with multiple…
Select Brain Stimulation May Ease MS Tremor, But More Study Needed
Electrically stimulating certain regions of the brain may help to ease tremors in people with multiple sclerosis (MS), but…
New Bouts of Depression, Anxiety Linked to Pandemic, US Survey Finds
Many people with multiple sclerosis (MS) report new bouts of depression and anxiety as a result of the COVID-19…
#AAN2022 – Phase 1 Data Shows NVG-291 Safe; Trial in MS Patients Anticipated
NVG-291, an experimental therapy designed to promote nervous system repair, has so far been well tolerated in an ongoing Phase…
#AAN2022 – CONSONANCE Update Shows Ocrevus’ Effectiveness After 1 Year
Nearly three of every four participants in the CONSONANCE clinical trial, which is evaluating Ocrevus (ocrelizumab) in people with…
#AAN2022 – Data from Multiple Trials Show Kesimpta’s Safety, Efficacy
Treatment with Kesimpta (ofatumumab) for more than three years revealed no new or unexpected safety findings, and continued to…
#AAN2022 – Ublituximab Bests Aubagio on Disability Measures
Ublituximab, an experimental therapy for relapsing multiple sclerosis (MS) patients, outperformed Aubagio on a number of disability-related outcomes…
No Link Between Herpes Infection and MS Risk in Genetic Study
Infection with the herpes simplex virus does not increase the risk of multiple sclerosis (MS), according to a new…
MS Society of Canada Grants Will Support 66 Research Projects
The MS Society of Canada is providing thousands in funding to 66 research projects that aim to accelerate scientific…
STAT5 Protein Complex Implicated in MS Autoimmunity in Mice
A four-protein complex, or tetramer, of the protein STAT5 is involved in the development of multiple sclerosis (MS)-like autoimmune…
Scientists Review State of Cannabis Research in MS
Treatment with cannabis-based medications may ease muscle spasms, decrease pain, and aid in sleep for people with multiple sclerosis…
Smell Test Might Help Predict if MS Treatments Are Working
A measure of the nose’s sensitivity to smell could be used to detect whether treatments for relapsing multiple sclerosis…
MS Doctors, Nurses in UK Struggle With Marking Transition to SPMS
Among healthcare providers in the U.K., considerable variation exists in marking the transition from relapsing-remitting multiple sclerosis (RRMS) to…
BCG Vaccine for TB Not Linked to MS Risk: Large Canadian Study
Getting the Bacillus Calmette-Guerin (BCG) vaccine to protect against tuberculosis (TB) — an immunization often given to infants and small…
Novantrone Lowers Relapses, Eases Disability in Highly Active RRMS
Initial treatment with Novantrone (mitoxantrone) can reduce the risk of relapses and worsening disability in people with highly active…
Drinking Alcohol Daily May Speed Loss of Nerve Cells in Patients’ Brains
While people who smoke cigarettes are more likely to be diagnosed with multiple sclerosis, MS patients who are daily…